Living PlatformLtd Past Earnings Performance
Past criteria checks 3/6
Living PlatformLtd's earnings have been declining at an average annual rate of -5.3%, while the Healthcare industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 17.8% per year. Living PlatformLtd's return on equity is 11.4%, and it has net margins of 1.1%.
Key information
-5.3%
Earnings growth rate
-6.5%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 17.8% |
| Return on equity | 11.4% |
| Net Margin | 1.1% |
| Next Earnings Update | 14 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Living PlatformLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 16,662 | 189 | 1,528 | 0 |
| 31 Dec 23 | 15,790 | 132 | 1,820 | 0 |
| 30 Sep 23 | 15,090 | 87 | 1,768 | 0 |
| 30 Jun 23 | 14,315 | 70 | 1,676 | 0 |
| 31 Mar 23 | 13,694 | 91 | 1,516 | 0 |
| 31 Dec 22 | 13,391 | 107 | 1,133 | 0 |
| 30 Sep 22 | 13,019 | 200 | 1,017 | 0 |
| 30 Jun 22 | 12,345 | 223 | 931 | 0 |
| 31 Mar 22 | 11,625 | 407 | 862 | 0 |
| 31 Dec 21 | 10,884 | 415 | 784 | 0 |
| 30 Sep 21 | 10,176 | 479 | 756 | 0 |
| 30 Jun 21 | 9,683 | 392 | 743 | 0 |
| 31 Mar 21 | 9,132 | 56 | 748 | 0 |
| 31 Dec 20 | 8,818 | 28 | 783 | 0 |
| 31 Mar 20 | 7,730 | 104 | 699 | 0 |
| 31 Mar 19 | 6,627 | 158 | 576 | 0 |
| 31 Mar 18 | 5,679 | 76 | 500 | 0 |
Quality Earnings: 7091 has a large one-off gain of ¥61.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 7091's current net profit margins (1.1%) are higher than last year (0.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7091's earnings have declined by 5.3% per year over the past 5 years.
Accelerating Growth: 7091's earnings growth over the past year (107.7%) exceeds its 5-year average (-5.3% per year).
Earnings vs Industry: 7091 earnings growth over the past year (107.7%) exceeded the Healthcare industry 14.3%.
Return on Equity
High ROE: 7091's Return on Equity (11.4%) is considered low.